Amino Acids

, Volume 51, Issue 2, pp 205–218 | Cite as

Studies on acid stability and solid-phase block synthesis of peptide–peptoid hybrids: ligands for formyl peptide receptors

  • Anna Mette Hansen
  • Sarah Line Skovbakke
  • Simon Bendt Christensen
  • Iris Perez-Gassol
  • Henrik FranzykEmail author
Original Article


α-Peptoids as well as peptide/α-peptoid hybrids and peptide/β-peptoid hybrids constitute major classes of proteolytically stable peptidomimetics that have been extensively investigated as mimetics of biologically active peptides. Representatives of lipidated peptide/β-peptoid hybrids have been identified as promising immunomodulatory lead compounds, and hence access to these via protocols suitable for gram-scale synthesis is warranted to enable animal in vivo studies. Recent observations indicated that several byproducts appear in crude mixtures of relatively short benzyl-based peptide/β-peptoid oligomers, and that these were most predominant when the β-peptoid units displayed an α-chiral benzyl side chain. This prompted an investigation of their stability under acidic conditions. Simultaneous deprotection and cleavage of peptidomimetics containing either α-chiral α- or β-peptoid residues required treatment with strong acid only for a short time to minimize the formation of partially debenzylated byproducts. The initial work on peptide/β-peptoid oligomers with an alternating design established that it was beneficial to form the amide bond between the carboxyl group of the α-amino acid and the congested amino functionality of the β-peptoid residue in solution. To further simplify oligomer assembly on solid phase, we now present a protocol for purification-free solid-phase synthesis of tetrameric building blocks. Next, syntheses of peptidomimetic ligands via manual solid-phase methodologies involving tetrameric building blocks were found to give more readily purified products as compared to those obtained with dimeric building blocks. Moreover, the tetrameric building blocks could be utilized in automated synthesis with microwave-assisted heating, albeit the purity of the crude products was not increased.


Peptidomimetics Peptoids Solid-phase synthesis Acid stability Formyl peptide receptor ligands 



We acknowledge Birgitte Simonsen for the purification of peptidomimetics. NMR equipment used in this work was purchased via Grant No. 10-085264 from The Danish Research Council for Independent Research|Nature and Universe.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

All authors listed have contributed to conception, design, synthesis, gathering, analysis, or interpretation of data, and have contributed to the writing and intellectual content of the article. All authors gave informed consent to the submission of this manuscript.

Supplementary material

726_2018_2656_MOESM1_ESM.pdf (1.4 mb)
Supplementary material 1 (PDF 1426 kb)


  1. Bacsa B, Horvati K, Bosze S, Andreae F, Kappe CO (2008) Solid-phase synthesis of difficult peptide sequences at elevated temperatures: a critical comparison of microwave and conventional heating technologies. J Org Chem 73:7532–7542. CrossRefPubMedGoogle Scholar
  2. Bang JK, Nan YH, Lee EK, Shin SY (2010) A novel Trp-rich model antimicrobial peptoid with increased protease stability. Bull Korean Chem Soc 31:2509–2513. CrossRefGoogle Scholar
  3. Birtalan E, Rudat B, Kölmel DK, Fritz D, Vollrath SBL, Schepers U, Bräse S (2011) Investigating rhodamine B-labeled peptoids: scopes and limitations of its applications. Biopolymers 96:694–701. CrossRefPubMedGoogle Scholar
  4. Bolt HL, Eggimann GA, Jahoda CAB, Zuckermann RN, Sharples GJ, Cobb SL (2017) Exploring the links between peptoid antibacterial activity and toxicity. MedChemComm 8:886–896. CrossRefPubMedPubMedCentralGoogle Scholar
  5. Bonke G, Vedel L, Witt M, Jaroszewski JW, Olsen CA, Franzyk H (2008) Dimeric building blocks for solid-phase synthesis of α-peptide–β-peptoid chimeras. Synthesis 2008(15):2381–2390. CrossRefGoogle Scholar
  6. Chongsiriwatana NP, Patch JA, Czyzewski AM, Dohm MT, Ivankin A, Gidalevitz D, Zuckermann RN, Barron AE (2008) Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci USA 105:2794–2799. CrossRefPubMedGoogle Scholar
  7. de la Torre BG, Jakab A, Andreu D (2007) Polyethyleneglycol-based resins as solid supports for the synthesis of difficult or long peptides. Int J Pept Res Ther 13:265–270. CrossRefGoogle Scholar
  8. Eggenberger K, Birtalan E, Schröder T, Bräse S, Nick P (2009) Passage of Trojan peptoids into plant cells. ChemBioChem 10:2504–2512. CrossRefPubMedGoogle Scholar
  9. Findlay B, Szelemej P, Zhanel GG, Schweizer F (2012) Guanidylation and tail effects in cationic antimicrobial lipopeptoids. PLoS One 7:e41141. CrossRefPubMedPubMedCentralGoogle Scholar
  10. Forsman H, Andréasson E, Karlsson J, Boulay F, Rabiet MJ, Dahlgren C (2012) Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin. J Immunol 189:629–637. CrossRefPubMedGoogle Scholar
  11. Fowler SA, Blackwell HE (2009) Structure–function relationships in peptoids: recent advances toward deciphering the structural requirements for biological function. Org Biomol Chem 7:1508–1524. CrossRefPubMedPubMedCentralGoogle Scholar
  12. Fowler SA, Luechapanichkul R, Blackwell HE (2009) Synthesis and characterization of nitroaromatic peptoids: fine tuning peptoid secondary structure through monomer position and functionality. J Org Chem 74:1440–1449. CrossRefPubMedPubMedCentralGoogle Scholar
  13. Garcia-Martin F, Quintanar-Audelo M, Garcia-Ramos Y, Cruz LJ, Gravel C, Furic R, Côte S, Tulla-Puche J, Albericio F (2006) ChemMatrix, a poly(ethylene glycol)-based support for the solid-phase synthesis of complex peptides. J Comb Chem 8:213–220. CrossRefPubMedGoogle Scholar
  14. Goodson B, Ehrhardt A, Ng S, Nuss J, Johnson K, Giedlin M, Yamamoto R, Moos WH, Krebber A, Ladner M, Giacone MB, Vitt C, Winter J (1999) Characterization of novel antimicrobial peptoids. Antimicrob Agents Chemother 43:1429–1434. CrossRefPubMedPubMedCentralGoogle Scholar
  15. Gorske BC, Blackwell HE (2006) Tuning peptoid secondary structure with pentafluoroaromatic functionality: a new design paradigm for the construction of discretely folded peptoid structures. J Am Chem Soc 128:14378–14387. CrossRefPubMedGoogle Scholar
  16. Hamper BC, Kolodziej SA, Scatez AM, Smith RG, Cortez E (1998) Solid phase synthesis of β-peptoids: N-substituted β-aminopropionic acid oligomers. J Org Chem 63:708–718. CrossRefPubMedGoogle Scholar
  17. Hansen PR, Munk JK (2013) Synthesis of antimicrobial peptoids. Methods Mol Biol 1047:151–159. CrossRefPubMedGoogle Scholar
  18. Hein-Kristensen L, Knapp KM, Franzyk H, Gram L (2011) Bacterial membrane activity of α-peptide/β-peptoid chimeras: influence of amino acid composition and chain length on the activity against different bacterial strains. BMC Microbiol 11:144. CrossRefPubMedPubMedCentralGoogle Scholar
  19. Holdfeldt A, Skovbakke SL, Winther M, Gabl M, Nielsen C, Perez-Gassol I, Larsen CJ, Wang JM, Karlsson A, Dahlgren C, Forsman H, Franzyk H (2016) The lipidated peptidomimetic Lau-((S)-Aoc)-(Lys-βNphe)6-NH2 is a novel formyl peptide receptor 2 agonist that activates both human and mouse neutrophil NADPH oxidase. J Biol Chem 291:19888–19899. CrossRefPubMedPubMedCentralGoogle Scholar
  20. Jahnsen RD, Frimodt-Møller N, Franzyk H (2012) Antimicrobial activity of peptidomimetics against multidrug-resistant Escherichia coli: a comparative study of different backbones. J Med Chem 55:7253–7261. CrossRefPubMedGoogle Scholar
  21. Jahnsen RD, Haney EF, Franzyk H, Hancock REW (2013) Characterization of a proteolytically stable multifunctional host defense peptidomimetic. Chem Biol 20:1286–1295. CrossRefPubMedGoogle Scholar
  22. Jahnsen RD, Sandberg-Schaal A, Vissing KJ, Nielsen HM, Frimodt-Møller N, Franzyk H (2014) Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli. J Med Chem 57:2864–2873. CrossRefPubMedGoogle Scholar
  23. Kim J-K, Lee S-A, Shin S, Lee J-Y, Jeong K-W, Nan YH, Park YS, Shin SY, Kim Y (2010) Structural flexibility and the positive charges are the key factors in bacterial cell selectivity and membrane penetration of peptoid-substituted analog of piscidin 1. Biochim Biophys Acta 1798:1913–1925. CrossRefPubMedGoogle Scholar
  24. Kirshenbaum K, Barron AE, Goldsmith RA, Armand P, Bradley EK, Truong KTV, Dill KA, Cohen FE, Zuckermann RN (1998) Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure. Proc Natl Acad Sci USA 95:4303–4308. CrossRefPubMedGoogle Scholar
  25. Kruijtzer JAW, Hofmeyer LJF, Heerma W, Versluis C, Liskamp RMJ (1998) Solid-phase syntheses of peptoids using Fmoc-protected N-substituted glycines: the synthesis of (retro) peptoids of Leu-enkephalin and substance P. Chem Eur J 4:1570–1580.;2-2 CrossRefGoogle Scholar
  26. Lin H, Yan TT, Wang L, Guo FF, Ning GS, Xiong M (2016) Statistical design, structural analysis, and in vitro susceptibility assay of antimicrobial peptoids to combat bacterial infections. J Chemometr 30:369–376. CrossRefGoogle Scholar
  27. Liu Y, Knapp KM, Yang L, Molin S, Franzyk H, Folkesson A (2013) High in vitro antimicrobial activity of β-peptoid-peptide hybrid oligomers against planktonic and biofilm cultures of Staphylococcus epidermidis. Int J Antimicrob Agents 41:20–27. CrossRefPubMedGoogle Scholar
  28. Mojsoska B, Jenssen H (2015) Peptides and peptidomimetics for antimicrobial drug design. Pharmaceuticals 8:366–415. CrossRefPubMedPubMedCentralGoogle Scholar
  29. Mojsoska B, Zuckermann RN, Jenssen H (2015) Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides. Antimicrob Agents Chemother 59:4112–4120. CrossRefPubMedPubMedCentralGoogle Scholar
  30. Molchanova N, Hansen PR, Franzyk H (2017) Advances in development of antimicrobial peptidomimetics as potential drugs. Molecules 22:1430. CrossRefPubMedCentralGoogle Scholar
  31. Norgren AS, Zhang S, Arvidsson PI (2006) Synthesis and circular dichroism spectroscopic investigations of oligomeric β-peptoids with α-chiral side chains. Org Lett 8:4533–4536. CrossRefPubMedGoogle Scholar
  32. Olsen CA (2010) Peptoid-peptide hybrid backbone architectures. ChemBioChem 11:152–160. CrossRefPubMedGoogle Scholar
  33. Olsen CA, Lambert M, Witt M, Franzyk H, Jaroszewski JW (2008) Solid-phase peptide synthesis and circular dichroism study of chiral β-peptoid homooligomers. Amino Acids 34:465–471. CrossRefPubMedGoogle Scholar
  34. Rothbard JB, Kreider E, Pattabiraman K, Pelkey ET, VanDeusen CL, Wright L, Wylie BL, Wender PA (2002) Arginine-rich molecular transporters for drugs: the role of backbone and side chain variations on cellular uptake. In: Langel Ü (ed) Cell-penetrating peptides: processes and applications. CRC Press LLC, Boca Raton, pp 142–160Google Scholar
  35. Ryge TS, Frimodt-Møller N, Hansen PR (2008) Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. Chemotherapy 54:152–156. CrossRefPubMedGoogle Scholar
  36. Schröder T, Niemeier N, Afonin S, Ulrich AS, Krug HF, Bräse S (2008) Peptoidic amino- and guanidinium-carrier systems: targeted drug delivery into the cell cytosol or the nucleus. J Med Chem 51:376–379. CrossRefPubMedGoogle Scholar
  37. Shin SY (2014) Effect of double replacement of L-pro, D-pro, D-leu or Nleu in hydrophobic face of amphipathic α-helical model antimicrobial peptide on structure, cell selectivity and mechanism of action. Bull Korean Chem Soc 35:3267–3274. CrossRefGoogle Scholar
  38. Shuey SW, Delaney WJ, Shah MC, Scialdone MA (2006) Antimicrobial β-peptoids by a block synthesis approach. Bioorg Med Chem Lett 16:1245–1248. CrossRefPubMedGoogle Scholar
  39. Simon RJ, Kania RS, Zuckermann RN, Huebner VD, Jewell DA, Banville S, Ng S, Wang L, Rosenberg S, Marlowe CK (1992) Peptoids: a modular approach to drug discovery. Proc Natl Acad Sci USA 89:9367–9371. CrossRefPubMedGoogle Scholar
  40. Skovbakke SL, Heegaard PMH, Larsen CJ, Franzyk H, Forsman H, Dahlgren C (2015a) The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2. Biochem Pharmacol 93:182–195. CrossRefPubMedGoogle Scholar
  41. Skovbakke SL, Larsen CJ, Heegaard PMH, Moesby L, Franzyk H (2015b) Lipidated α-peptide/β-peptoid hybrids with potent antiinflammatory activity. J Med Chem 58:801–813. CrossRefPubMedGoogle Scholar
  42. Skovbakke SL, Winther M, Gabl M, Holdfeldt A, Linden S, Wang JM, Dahlgren C, Franzyk H, Forsman H (2016) The peptidomimetic Lau-(Lys-βNSpe)6-NH2 antagonizes formyl peptide receptor 2 expressed in mouse neutrophils. Biochem Pharmacol 119:56–65. CrossRefPubMedGoogle Scholar
  43. Skovbakke SL, Holdfeldt A, Nielsen C, Hansen AM, Perez-Gassol I, Dahlgren C, Forsman H, Franzyk H (2017) Combining elements from two antagonists of formyl peptide receptor 2 generates more potent peptidomimetic antagonists. J Med Chem 60:6991–6997. CrossRefPubMedGoogle Scholar
  44. Stanzl EG, Trantow BM, Vargas JR, Wender PA (2013) Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications. Acc Chem Res 46:2944–2954. CrossRefPubMedGoogle Scholar
  45. Wu CW, Sanborn TJ, Zuckermann RN, Barron AE (2001) Peptoid oligomers with α-chiral, aromatic side chains: effects of chain length on secondary structure. J Am Chem Soc 123:2958–2963. CrossRefPubMedGoogle Scholar
  46. Zuckermann RN (2011) Peptoid origins. Pept Sci 96:545–555. CrossRefGoogle Scholar
  47. Zuckermann RN, Kodadek T (2009) Peptoids as potential therapeutics. Curr Opin Mol Ther 11:299–307PubMedGoogle Scholar
  48. Zuckermann RN, Kerr JM, Kent SBH, Moos WH (1992) Efficient method for the preparation of peptoids (oligo(N-substituted glycines)) by submonomer solid-phase synthesis. J Am Chem Soc 114:10646–10647. CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Drug Design and Pharmacology, Faculty of Health and Medical SciencesUniversity of CopenhagenCopenhagenDenmark
  2. 2.Department of Veterinary and Animal Sciences, Faculty of Health and Medical SciencesUniversity of CopenhagenFrederiksbergDenmark

Personalised recommendations